Weizhen Zhu

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Impact of PSMA PET on the management and clinical outcomes of patients with biochemical failure of prostate cancer after definitive treatment: a systematic review and meta-analysis.

Impact of PSMA PET on the management and clinical outcomes of patients with biochemical failure of prostate cancer after definitive treatment: a systematic review and meta-analysis.

Journal: International urology and nephrology
Published: January 15, 2026

Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection.

Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection.

Journal: MedComm
Published: November 16, 2025

Gut microbial metabolites in cancer immunomodulation.

Gut microbial metabolites in cancer immunomodulation.

Journal: Molecular cancer
Published: September 08, 2025

Abbreviated biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.

Abbreviated biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.

Journal: International journal of surgery (London, England)
Published: April 15, 2025

Decoding GDF15: Impact on prostate cancer metabolism, chemoresistance, and clinical applications.

Decoding GDF15: Impact on prostate cancer metabolism, chemoresistance, and clinical applications.

Journal: Chinese medical journal
Published: November 06, 2024

DEMINERS enables clinical metagenomics and comparative transcriptomic analysis by increasing throughput and accuracy of nanopore direct RNA sequencing.

DEMINERS enables clinical metagenomics and comparative transcriptomic analysis by increasing throughput and accuracy of nanopore direct RNA sequencing.

Journal: Genome biology
Published: August 22, 2024

Expanding horizons in theragnostics: from oncology to multidisciplinary applications.

Expanding horizons in theragnostics: from oncology to multidisciplinary applications.

Journal: La Radiologia medica
Published: June 06, 2024

Androgen-ablative therapies inducing CXCL8 regulates mTORC1/SREBP2-dependent cholesterol biosynthesis to support progression of androgen receptor negative prostate cancer cells.

Androgen-ablative therapies inducing CXCL8 regulates mTORC1/SREBP2-dependent cholesterol biosynthesis to support progression of androgen receptor negative prostate cancer cells.

Journal: Oncogene
Published: May 25, 2024

Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions.

Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions.

Journal: Aging and disease
Published: March 03, 2024

Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients.

Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients.

Journal: Aging
Published: February 02, 2023

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.

Journal: European journal of medical research
Published: November 29, 2022

Pyroptosis in urinary malignancies: a literature review.

Pyroptosis in urinary malignancies: a literature review.

Journal: Discover oncology
Published: October 31, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026